Iterum Therapeutics plc (ITRM)
NASDAQ: ITRM · Real-Time Price · USD
0.930
0.00 (0.01%)
At close: Oct 11, 2024, 4:00 PM
0.940
+0.010 (1.04%)
After-hours: Oct 11, 2024, 6:56 PM EDT
Iterum Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | - | - | - | - | - | 0.04 | |
| Revenue Growth (YoY) | - | - | - | - | - | -95.74% | |
| Gross Profit | - | - | - | - | - | 0.04 | |
| Selling, General & Admin | 7.61 | 7.48 | 12.77 | 13.83 | 11.05 | 11.28 | |
| Research & Development | 30.65 | 39.99 | 17.62 | 10.71 | 21.07 | 90.77 | |
| Operating Expenses | 38.26 | 47.47 | 30.38 | 24.54 | 32.13 | 102.06 | |
| Operating Income | -38.26 | -47.47 | -30.38 | -24.54 | -32.13 | -102.02 | |
| Interest Expense | -3.49 | -3.15 | -3.18 | -4.53 | -12.3 | -1.76 | |
| Interest & Investment Income | 1.72 | 1.72 | 0.82 | - | - | 0.9 | |
| Other Non Operating Income (Expenses) | 12.06 | 11.14 | -11.39 | -61.79 | -7.18 | 0.2 | |
| EBT Excluding Unusual Items | -27.96 | -37.76 | -44.13 | -90.86 | -51.6 | -102.69 | |
| Other Unusual Items | - | - | - | - | 0.34 | - | |
| Pretax Income | -27.96 | -37.76 | -44.13 | -90.86 | -51.26 | -102.69 | |
| Income Tax Expense | 0.38 | 0.61 | 0.3 | 0.71 | 0.74 | 0.44 | |
| Net Income | -28.34 | -38.37 | -44.43 | -91.56 | -52.01 | -103.13 | |
| Net Income to Common | -28.34 | -38.37 | -44.43 | -91.56 | -52.01 | -103.13 | |
| Shares Outstanding (Basic) | 15 | 13 | 12 | 11 | 2 | 1 | |
| Shares Outstanding (Diluted) | 15 | 13 | 12 | 11 | 2 | 1 | |
| Shares Change (YoY) | 16.06% | 5.93% | 12.35% | 580.42% | 65.38% | 66.22% | |
| EPS (Basic) | -1.95 | -2.96 | -3.63 | -8.41 | -32.49 | -106.55 | |
| EPS (Diluted) | -1.95 | -2.96 | -3.63 | -8.41 | -32.49 | -106.55 | |
| Free Cash Flow | -41.95 | -39.34 | -18.54 | -15.9 | -54.54 | -81.95 | |
| Free Cash Flow Per Share | -2.88 | -3.04 | -1.51 | -1.46 | -34.07 | -84.67 | |
| Gross Margin | - | - | - | - | - | 100.00% | |
| Operating Margin | - | - | - | - | - | -275732.43% | |
| Profit Margin | - | - | - | - | - | -278729.73% | |
| Free Cash Flow Margin | - | - | - | - | - | -221475.68% | |
| EBITDA | -37.36 | -45.72 | -28.58 | -22.43 | -31.97 | -101.87 | |
| D&A For EBITDA | 0.89 | 1.75 | 1.8 | 2.1 | 0.16 | 0.15 | |
| EBIT | -38.26 | -47.47 | -30.38 | -24.54 | -32.13 | -102.02 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.